Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Hedge Funds

Hedge fund buys 6.6% stake in Durham's BioCryst Pharma

by wraltechwire.com posted 1year ago 258 views
​A New York City hedge fund bought a 6.6 percent stake of a North Carolina pharmaceutical company, according to an SEC filing.

In this article